President Donald Trump signed an executive order Monday aiming to significantly reduce prescription drug prices in the United ...

Catalysts anchor Julie Hyman and guest host, Great Hill Capital chairman and managing member Thomas Hayes, cover a wide array ...

Defects in hepatic insulin action in type 2 diabetes and its possible underlying mechanisms were assessed in euglycemic-hyperinsulinemic clamp studies, using improved tracer methods (constant ...

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its ...

UnitedHealth Group faces real PBM reform risks, but legal paths, financials, and market pricing suggest opportunity in ...

CGM recommended optimal settings vs non-recommended settings were associated with superior glycemic control among patients ...

The use of GLP-1s among patients with type 2 diabetes appeared associated with significantly reduced risk for certain hematologic malignancies compared with insulin and metformin use, according to ...

UNLOXCYT (cosibelimab-ipdl) approved by U.S. FDA in December 2024 as first and only anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma Special meeting of stockholders to vote on Merge ...

The president spoke with House Republicans for more than an hour on Tuesday in what appeared to be part pep rally, part pressure campaign. She's the brains behind the best-selling novels loved by ...